Pay in 4 interest-free payments of $5.79 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
AOD-9604 is currently sold for research purposes only and lacks regulatory approval from any major health authority worldwide
Those wanting added folate and methylcobalamin in a B-complex formula
OASIS trials: establishing effective doses Phase 2 OASIS 1 findings: Tested multiple dose levels: 0.3mg, 0.6mg, 1.2mg, 2.4mg, 4.5mg weekly Duration: 26 weeks Primary endpoint: Weight loss at each dose Dose-response results: 0.3mg weekly: ~4% body weight loss 0.6mg weekly: ~6% body weight loss 1.2mg weekly: ~8% body weight loss 2.4mg weekly: ~10% body weight loss 4.5mg weekly: ~12% body weight loss Key insight: Clear dose-response relationship
Book a consultation at your nearest Oliva Clinics today
CJC-1295 no DAC CJC-1295 No DAC is a synthetic growth hormone-releasing hormone (GHRH) analog
